SCOPUS 정보 검색 플랫폼

Volumn 14, Issue 2, 1996, Pages 219-222

A phase II trial of ilmofosine in non-small cell bronchogenic carcinoma

(8) Woolley, Paul V a,e Schultz, Carolyn J a Rodriguez, Gladys I b Gams, Richard A c Rowe Jr , Kenneth W a Dadey, Mary Lee a Von Hoff, Daniel D b McPhillips, Joseph J d

a Laurel Highlands Cancer Program (United States)

b University of Texas Health Science Center at San Antonio (United States)

c OHIO STATE UNIVERSITY (United States)

d F HOFFMANN LA ROCHE LTD (Switzerland)

e Laurel Highlands Cancer Program (United States)

Author keywords

Ether lipids; Ilmofosine; Non small cell lung cancer; Phase II trials

Indexed keywords

ANTINEOPLASTIC AGENT; ILMOFOSINE;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; DIARRHEA; FATIGUE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER TOXICITY; LUNG CARCINOMA; MALE; NAUSEA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; TUMOR REGRESSION; VOMITING;

EID: 0029825156 PISSN: 01676997 EISSN: None Source Type: Journal
DOI: 10.1007/BF00210794 Document Type: Article

Times cited : (14)

References (6)

1
- 0026781992
- Preclinical activity of ilmofosine against human tumor colony forming units in vitro
- Hanauske A, Degen D, Marshall MH, Hilsenbeck SG, McPhillips JJ, Von Hoff DD: Preclinical activity of ilmofosine against human tumor colony forming units in vitro. Anti-Cancer Drugs 3:43-46, 1992
- (1992) Anti-Cancer Drugs , vol.3 , pp. 43-46
- Hanauske, A.¹ Degen, D.² Marshall, M.H.³ Hilsenbeck, S.G.⁴ McPhillips, J.J.⁵ Von Hoff, D.D.⁶

2
- 0025572694
- In vivo antitumor activity of ilmofosine
- Herrmann DB, Pahlke W, Opitz H-G, Bicker U: In vivo antitumor activity of ilmofosine. Cancer Treat Rev 17:247-252, 1990
- (1990) Cancer Treat Rev , vol.17 , pp. 247-252
- Herrmann, D.B.¹ Pahlke, W.² Opitz, H.-G.³ Bicker, U.⁴

3
- 0026323480
- Antitumor activity of ilmofosine (BM41440) in the 3 Lewis-lung carcinoma model
- Herrman DBJ, Opitz H-G, Munder PG: Antitumor activity of ilmofosine (BM41440) in the 3 Lewis-lung carcinoma model. Lipids 26:1431-1436, 1991
- (1991) Lipids , vol.26 , pp. 1431-1436
- Herrman, D.B.J.¹ Opitz, H.-G.² Munder, P.G.³

4
- 1642355962
- Phase I clinical trial of ilmofosine, a novel antitumor agent
- Rodriguez G, Havlin K, Burris H, Wall J, Schaffer D, Smith L, Kalter S, Brown T, Cagnola J, Weiss G, Kneuper Hall R, Von Hoff D: Phase I clinical trial of ilmofosine, a novel antitumor agent. Proc Am Soc Clin Oncol (Abstract) 10:114, 1991
- (1991) Proc Am Soc Clin Oncol (Abstract) , vol.10 , pp. 114
- Rodriguez, G.¹ Havlin, K.² Burris, H.³ Wall, J.⁴ Schaffer, D.⁵ Smith, L.⁶ Kalter, S.⁷ Brown, T.⁸ Cagnola, J.⁹ Weiss, G.¹⁰ Kneuper Hall, R.¹¹ Von Hoff, D.¹²

5
- 27044441051
- Phase I pharmacokinetic trial of weekly ilmofosine (BM41440)
- Rodriguez G, O'Dwyer PJ, Deny C, McAleer C, McPhillips J, Ozols RF: Phase I pharmacokinetic trial of weekly ilmofosine (BM41440). Proc Am Soc Clin Oncol (Abstract) 12:157, 1993
- (1993) Proc Am Soc Clin Oncol (Abstract) , vol.12 , pp. 157
- Rodriguez, G.¹ O'Dwyer, P.J.² Deny, C.³ McAleer, C.⁴ McPhillips, J.⁵ Ozols, R.F.⁶

6
- 27044434020
- Phase I study of ilmofosine given as a 120 hour continuous infusion in patients with solid tumors
- Koeller J, Rodriguez G, Smith L, Eckardt J, Shaffer D, Weiss G, Higashi L, McPhillips J, Von Hoff D: Phase I study of ilmofosine given as a 120 hour continuous infusion in patients with solid tumors. Proc Am Soc Clin Oncol 12:155, 1993
- (1993) Proc Am Soc Clin Oncol , vol.12 , pp. 155
- Koeller, J.¹ Rodriguez, G.² Smith, L.³ Eckardt, J.⁴ Shaffer, D.⁵ Weiss, G.⁶ Higashi, L.⁷ McPhillips, J.⁸ Von Hoff, D.⁹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.